| Ticker Details |
Medtronic plc
Medtronic PLC is a medical technology company. It is primarily manufactures and sells device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$112.87B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.59 | 0.87%
|
| Avg Daily Range (30 D): |
$0.75 | 0.83%
|
| Avg Daily Range (90 D): |
$0.82 | 0.85%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.2M |
| Avg Daily Volume (30 D): |
6.47M |
| Avg Daily Volume (90 D): |
5.95M |
| Trade Size |
| Avg Trade Size (Sh.): |
140 |
| Avg Trade Size (Sh.) (30 D): |
70 |
| Avg Trade Size (Sh.) (90 D): |
68 |
| Institutional Trades |
| Total Institutional Trades: |
112,046 |
| Avg Institutional Trade: |
$4.86M |
| Avg Institutional Trade (30 D): |
$9.68M |
| Avg Institutional Trade (90 D): |
$12.1M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
19 |
| Market Closing Trades |
| Avg Closing Trade: |
$47.86M |
| Avg Closing Trade (30 D): |
$112.39M |
| Avg Closing Trade (90 D): |
$118.65M |
| Avg Closing Volume: |
578.68K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$3.72
|
$1.07
|
$.81
|
|
Diluted EPS
|
$3.7
|
$1.07
|
$.81
|
|
Revenue
|
$34.76B
|
$8.96B
|
$8.58B
|
|
Gross Profit
|
$22.77B
|
$5.9B
|
$5.58B
|
|
Net Income / Loss
|
$4.79B
|
$1.38B
|
$1.05B
|
|
Operating Income / Loss
|
$6.21B
|
$1.69B
|
$1.45B
|
|
Cost of Revenue
|
$11.99B
|
$3.06B
|
$3B
|
|
Net Cash Flow
|
$-112M
|
$9M
|
$-945M
|
|
PE Ratio
|
23.54
|
|
|
|
|
|